Tg Therapeutics, Inc.

NC · United States · Reporting entity ID 100000961857

Total reported 2019–2025

$51.1M

#173 of 2,960 reporting companies — 0.1% of all reported industry payments

$15.1M in general payments across 39,864 records, plus $35.9M in research funding across 9,437 records.

How it breaks down

General payments $15,129,979

Research funding $35,948,242

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.